Perception of acoustic frequencies in (Ab) users and non-users of psychedelics: a cross-sectional analytic study via the surface web

Paper Details

Research Paper 01/11/2018
Views (263) Download (7)
current_issue_feature_image
publication_file

Perception of acoustic frequencies in (Ab) users and non-users of psychedelics: a cross-sectional analytic study via the surface web

Ahmed Al-Imam
Int. J. Biosci.13( 5), 427-437, November 2018.
Certificate: IJB 2018 [Generate Certificate]

Abstract

Hallucinogenic substances, also known as psychedelics and entheogenic chemicals, are psychoactive substance possessing unique pharmacodynamics and pharmacokinetic properties. The literature points out some high-risk hallucinogens including those of super-potent properties active within the micro-dosing range. Psychedelics as well as several medicinal and non-medicinal chemicals can be ototoxic and can induce deafness. Our study aims to extrapolate, based on statistical inference, the existence of a potential correlation between the use of hallucinogens versus hearing loss. This study is observational cross-sectional analytic based on a survey presented to web users interacting via dedicated private groups on Facebook. The investigation will include atone (frequency) generator to test the hearing range of audible frequencies including the upper and lower limits of hearing. The study will also screen demographic parameters, and variables of interests including social and marital status, ethnicity, nationality, and pre-existing medical conditions. Hypothesis testing could notinfer any significant differences or association between the use of psychedelic substances and hearing loss. It seems that the (mis) use of psychedelics and the range of audible frequencies of (mis)users are independent of each other. However, our study has some confounding variable and limitations that will be pointed out. Future studies should incorporate animal models and controlled trials on humans to extrapolate rigour evidence concerning the potential pathophysiological effects of hallucinogens, including molecular changes, on the conductive and sensor neural mechanisms of hearing. Besides, observational studies should always attempt to be more representative, systematic, and strive to provide real-time and predictive analytics for specific populations of interest.

VIEWS 13

Al-Imam A. 2017. Adverse Effects of Amphetamines on the Cardiovascular System: Review and Retrospective Analyses of Trends. Global Journal of Health Science 9(11), 102.

Al-Imam A. 2017. Could Hallucinogens Induce Permanent Pupillary Changes in (Ab) users? A Case Report from New Zealand. Case reports in neurological medicine, 2017.

Al-Imam A. 2017. Google Trends Analyses and Case Report: A Persistently Dilated Pupil in Psychedelics’ User. Global Journal of Health Science 9(11), 168.

Al-Imam A. 2017. Retrospective Analyses of High-risk NPS: Integrative Analyses of PubMed, Drug Fora, and the Surface Web. Global Journal of Health Science 9(11), 40.

Al-Imam A. Monitoring and Analysis of Novel Psychoactive Substances in Trends Databases, Surface Web and the Deep Web, with Special Interest and Geo-Mapping of the Middle East. info: eu-repo/semantics/master Thesis [dissertation on the Internet]. United Kingdom: University of Hertfordshire; 2017. http://dx.doi.org/10.13140/RG. 2.2. 27636.24961.

Al-Imam A, Abdul Majeed BA. 2017. Novel Psychoactive Substances: Systematic Review and Evidence-Based Analysis of Literature. Global Journal of Health Science 9(11), 1.

Al-Imam A, Al-Mukhtar F, Shafiq A, Irfan M. 2017. Knowledge and (Ab) Use in Connection with Novel Psychoactive Substances: A Cross-Sectional Analysis of Iraqi Medical Students. Global Journal of Health Science 9(11), 61.

Al-imam A, Santacroce R, Roman-Urrestarazu A, Chilcott R, Bersani G, Martinotti G, Corazza O. 2017. Captagon: use and trade in the Middle East. Human Psychopharmacology: Clinical and Experimental 32(3), e2548.

Al-Imam A, Simonato AP, Corazza O. 2016. Haloperidol, an old antipsychotic with potential use by NPS users in Iraq. Research and Advances in Psychiatry 3(3), 81-84.

Al-Imam ML, Al-Imam A. 2017. Knowledge and (Ab) Use in Connection with Novel Psychoactive Substances: A Cross-Sectional Analysis of Psychedelic Users Existing on Online Platforms. Global Journal of Health Science 9(11), 51.

Aulet RM, Flis D, Sillman J. 2014. A Case of Heroin Induced Sensor neural Hearing Loss. Case reports in otolaryngology, 2014.

Catalani V, Prilutskaya M, Al-Imam A, Marrinan S, Elgharably Y, Zloh M, Corazza O. 2018. Octodrine: new questions and challenges in sport supplements. Brain Sciences 8(2), 34.

Christenson BJ, Marjala AR. 2010. Two cases of sudden sensor neural hearing loss after methadone overdose. Annals of Pharmacotherapy 44(1), 207-210.

Church MW, Zhang JS, Langford MM, Perrine SA. ‘Ecstasy ‘enhances noise-induced hearing loss. Hearing Research. 2013 Aug 1 302, 96-106.

Cruickshanks KJ, Wiley TL, Tweed TS, Klein BE, Klein R, Mares-Perlman JA, Nondahl DM. 1998. Prevalence of hearing loss in older adults in Beaver Dam, Wisconsin: The epidemiology of hearing loss study. American Journal of Epidemiology 148(9), 879-886.

Dalton DS, Cruickshanks KJ, Klein BE, Klein R, Wiley TL, Nondahl DM. 2003. The impact of hearing loss on quality of life in older adults. The Gerontologist 43(5), 661-668.

Dargan P, Wood D. Editors. Novel psychoactive substances: classification, pharmacology and toxicology. Academic Press; 2013 Aug 6.

De la Fuente Valentín L, Pardo A, Kloos CD. Using third party services to adapt learning material: A case study with Google forms. In European Conference on Technology Enhanced Learning 2009 Sep 29, p 744-750. Springer, Berlin, Heidelberg.

Dyck E. 2015. LSD: a new treatment emerging from the past. Canadian Medical Association Journal  187(14), 1079-1080.

Fisman M. 1991. Musical hallucinations: report of two unusual cases. The Canadian Journal of Psychiatry 36(8), 609-611.

Ginter KL, Shear VH, Spahn FJ, Van Wie DM, Weber RP. 2014. U.S. Patent No. 8,751,793. Washington, DC: U.S. Patent and Trademark Office.

Greenhalgh T, Howick J, Maskrey N. 2014. Evidence based medicine: a movement in crisis?. British Medical Journal 348, g3725.

Hanks JB, González-Maeso J. 2012. Animal models of serotonergic psychedelics. ACS Chemical Neuroscience 4(1), 33-42.

Hofmann A. 1970. The discovery of LSD and subsequent investigations on naturally occurring hallucinogens. Discoveries in Biological Psychiatry, 91-106.

Hofmann A. 1979. How LSD originated. Journal of Psychedelic Drugs 11(1-2), 53-60.

Howick J, Chalmers I, Glasziou P, Greenhalgh T, Heneghan C, Liberati A, Thornton H. 2011. Explanation of the 2011 Oxford Centre for Evidence-Based Medicine (OCEBM) levels of evidence (background document). Oxford Center for Evidence-Based Medicine.

Johnstad PG. 2018. Powerful substances in tiny amounts: An interview study of psychedelic micro dosing. Nordic Studies on Alcohol and Drugs 35(1), 39-51.

Kolp E, Friedman HL, Krupitsky E, Jansen K, Sylvester M, Young MS, Kolp A. 2014. Ketamine Psychedelic Psychotherapy: Focus on its Pharmacology, Phenomenology, and Clinical Applications. International Journal of Transpersonal Studies 33(2), 8.

Lopez IA, Ishiyama A, Ishiyama G. 2012, August). Sudden sensor neural hearing loss due to drug abuse. In Seminars in Hearing 33(3), 251-260. Thieme Medical Publishers.

Novac A, Iosif AM, Groysman R, Bota RG. 2015. Implications of sensor neural hearing loss with hydrocodone/acetaminophen abuse. The Primary Care Companion For CNS Disorders 17(5).

Roth TN, Hanebuth D, Probst R. 2011. Prevalence of age-related hearing loss in Europe: a review. European Archives of Oto-Rhino-Laryngology 268(8), 1101-1107.

Saifan C, Glass D, Barakat I, El-Sayegh S. 2013. Methadone induced sensor neural hearing loss. Case reports in Medicine, 2013.

Sara SA, Teh BM, Friedland P. Bilateral sudden sensor neural hearing loss. The Journal of Laryngology & Otology. 2014 Jan; 128(S1), S8-15.

Schreiber BE, Agrup C, Haskard DO, Luxon LM. 2010. Sudden sensor neural hearing loss. The Lancet 375(9721), 1203-1211.

Schweitzer VG, Darrat I, Stach BA, Gray E. 2011. Sudden bilateral sensor neural hearing loss following polysubstance narcotic overdose. Journal of the American Academy of Audiology 22(4), 208-214.

Sharma A. 2001. A case of sensor neural deafness following ingestion of Ecstasy. The Journal of Laryngology & Otology 115 (11), 911-915. Szynalski. com.

Turban E, King D, Lee JK, Liang TP, Turban DC. Overview of electronic commerce. In Electronic Commerce 2015, p 3-49. Springer, Cham.